Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
KKR Genetic Disorder L.P. Insider Profile
4 Followers
KKR Genetic Disorder L.P., Ten Percent Owner at BridgeBio Pharma, holds 25.26M shares in BridgeBio Pharma (Ticker: BBIO). Most recently, KKR Genetic Disorder L.P. Sold $5,800,000 shares of BridgeBio Pharma on Sep 17, 2024 for an estimated value of 149.35M.
KKR Genetic Disorder L.P. BridgeBio Pharma (BBIO)Ten Percent Owner
BridgeBio Pharma (BBIO)
Ten Percent Owner
Ranked #57,745 out of 99,335 Corporate Insiders
Profitable Transactions
2 out of 4 Profitable Transactions
Average Return
-5.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of KKR Genetic Disorder L.P.'s holdings
Insider Roles
Ten Percent Owner
Roles that KKR Genetic Disorder L.P. holds in companies
Most Profitable Insider Trade
The most profitable trade made by KKR Genetic Disorder L.P.
KKR Genetic Disorder L.P.'s Trading History
List of latest transactions for each holding click on a transaction to see KKR Genetic Disorder L.P.'s performance on stock
You May Also Like
KKR Genetic Disorder L.P. insider profile FAQ
What is the percentage of profitable transactions made by KKR Genetic Disorder L.P.?
The percentage of profitable transactions made by KKR Genetic Disorder L.P. is 50%.
What is the average return per transaction made by KKR Genetic Disorder L.P.?
The average return per transaction made by KKR Genetic Disorder L.P. is -5.60%.
What stocks does KKR Genetic Disorder L.P. hold?
KKR Genetic Disorder L.P. holds: BBIO stocks.
What was KKR Genetic Disorder L.P.’s latest transaction?
KKR Genetic Disorder L.P. latest transaction was an Informative Sell of $149.35M.
What was KKR Genetic Disorder L.P.'s most profitable transaction?
KKR Genetic Disorder L.P.’s most profitable transaction was an Informative Sell of BBIO stock on February 17, 2021. The return on the trade was 87.00%.
What is KKR Genetic Disorder L.P.'s role in BridgeBio Pharma?
KKR Genetic Disorder L.P.'s role in BridgeBio Pharma is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.